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(M.A. Nelson).eIF3f is a subunit of eukaryotic initiation factor 3 (eIF3). We previously showed that eIF3f is phos-
phorylated by cyclin dependent kinase 11 (CDK11p46) which is an important effector in apoptosis.
Here, we identiﬁed a second eIF3f phosphorylation site (Thr119) by CDK11p46 during apoptosis.
We demonstrated that eIF3f is directly phosphorylated by CDK11p46 in vivo. Phosphorylation of eIF3f
plays an important role in regulating its function in translation and apoptosis. Phosphorylation of
eIF3f enhances the association of eIF3f with the core eIF3 subunits during apoptosis. Our data sug-
gested that eIF3f may inhibit translation by increasing the binding to the eIF3 complex during apop-
tosis.
Structured summary:
MINT-6948874: EIF3b (uniprotkb:P55884) physically interacts (MI:0218) with EIF3f (uniprotkb:O00303)
by anti bait coimmunoprecipitation (MI:0006)
MINT-6948891: EIF3b (uniprotkb:P55884) physically interacts (MI:0218) with EIF3c (uniprotkb:Q99613),
EIF3a (uniprotkb:Q14152) and EIF3f (uniprotkb:O00303) by anti bait coimmunoprecipitation (MI:0006)
MINT-6948836, MINT-6948849, MINT-6948862: CDK11p46 (uniprotkb:P21127) phosphorylates
(MI:0217) EIF3f (uniprotkb:O00303) by protein kinase assay (MI:0424)
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction tor that binds to 40S ribosomes and promotes the binding ofCyclin dependent kinase 11 (CDK11) is a member of the cyclin-
dependent kinase family. Recent studies suggested that CDK11
interacts with cyclin L and may be involved in RNA processing or
transcription in proliferating cells [1–3]. An important function of
CDK11 is its contribution to apoptosis [4,5]. Upon apoptotic stim-
ulation, CDK11p110 is cleaved by caspases to generate a 46 kDa iso-
form that contains the catalytic domain of CDK11p110 which can
then phosphorylate other proteins [4,6,7].
We have identiﬁed eIF3f as a substrate of CDK11p46 [8]. Eukary-
otic initiation factor 3 (eIF3) is the largest translation initiation fac-chemical Societies. Published by E
1; eIF3, eukaryotic initiation
drogenase; GST, glutathione
to charge ratio
rgery, Arizona Cancer Center,
Rm5233, Tucson, AZ 85724,
.A. Nelson).
), mnelson@azcc.arizona.edumethionyl-tRNA and mRNA [9,10]. eIF3f contains the MPN/
Mov34 domain. We have demonstrated that CDK11p46 interacts
with the Mov34 domain of eIF3f in vitro and in vivo, and the inter-
action can be strengthened by the stimulation of apoptosis [8].
eIF3f is phosphorylated by CDK11p46 at Ser46 during apoptosis.
Furthermore, CDK11p46 inhibits translation both in vitro and
in vivo. We also demonstrated that eIF3f is a negative regulator
of translation [11]. Overexpression of eIF3f induces rRNA degrada-
tion and apoptosis [11]. Loss of the eIF3f gene allele has been ob-
served in melanoma and pancreatic cancer [12,13]. These
previous data provided insight into the function of CDK11p46 in
apoptotic signaling and also suggest that eIF3f may be a down-
stream death executer of CDK11p46. This is accomplished by inhib-
iting overall cellular translation.
The biological consequence of the phosphorylation of eIF3f by
CDK11p46 during apoptosis is not known. Here, we identiﬁed a sec-
ond site in eIF3f that is phosphorylated by CDK11p46 during apop-
tosis. We showed that alteration of the phosphorylation status of
eIF3f can signiﬁcantly inﬂuence its function in the regulation of
translation and apoptosis. We also demonstrated that the associationlsevier B.V. All rights reserved.
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apoptosis.
2. Materials and methods
2.1. Cell culture and treatments
A375 human melanoma cell line was obtained from American
Type Culture Collection (ATCC, Manassas, VA). The cells were cul-
tured in RPMI 1640 medium supplemented with 5% FBS. Cells were
transfected using Lipofectamine 2000 (Invitrogen).
2.2. Puriﬁcation of recombinant protein from Escherischia coli
Glutathione S-transferase (GST), GST-eIF3f and its truncated
proteins were puriﬁed and concentrated as described [8].
2.3. Kinase assay
The in vitro kinase assays were carried out as described [4,8]. For
in vivo kinase assay, 2 days after transfection, A375 cellswere prein-Fig. 1. CDK11p46 phosphorylates eIF3f at more than one site during apoptosis. (A) Kinase
with GST-eIF3f or eIF3fS46A. (B) Kinase assay was performed with GST or four truncat
constructs of eIF3f. (D) MS identiﬁcation of Thr119 phosphorylation. (E) Kinase assay
Staurosporine treated A375 cells were immunoprecipitated with eIF3 antibody followedcubated inphosphate-freemediumfor2 h. Themediumwas thenre-
placed with medium containing 200 lCi of H332PO4 for 2.5 h. The
cellswere then lysed and immunoprecipitated using eIF3f antibody.
The incorporation of 32P was detected by autoradiography.2.4. Identiﬁcation of eIF3f phosphorylation site
Caspase-processed CDK11p46 was immunoprecipitated from
staurosporine treated A375 cells. Recombinant eIF3f-1 protein
was then phosphorylated by the CDK11p46 and analyzed for phos-
phoamino acids by mass spectrometry (MS) as described [4,8].2.5. Immunoprecipitation and Western blotting
Immunoprecipitation and Western blotting was performed as
described [8]. eIF3, eIF3f and CDK11 antibodies were raised in goat
and rabbit as described [14,8]. Phosphothreonine, a-tubulin, goat
polyclonal eIF3a, eIF3g (eIF3b), and eIF3c antibodies were pur-
chased from Sigma, Oncogene and Santa Cruz Biotechnology Inc.
(Santa Cruz, CA).assay: CDK11p46 was immunoprecipitated from apoptotic A375 cells and incubated
ed eIF3f proteins as substrates. (C) Diagram of Mov34 domain and four deletion
s were performed with eIF3f-1 (T119) and eIF3f-1T119A (T119A) as substrates. (F)
by immunoblot with phosphothreonine or eIF3f antibody.
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The 2D gel electrophoresis was performed according to the
ReadyStrip IPG strip instruction manual of Bio-Rad.
2.7. Quantitative RT-PCR
RT-PCR was performed as described [8].
2.8. Cell free in vitro translation assay
A rabbit reticulocyte lysate in vitro translation system (Promega,
Madison, WI) was used to measure the translation level, which is
indicated by luciferase activity as previously described [8]. The
recombinant proteins were puriﬁed as described previously by
our group [8,11].
2.9. Apoptosis assay
Apoptosis was measured by Acridine Orange and Ethidium
Bromide staining (100 lg/ml of each dye) and ﬂuorescent micro-
scopy as described [11]. Caspase 3/7 activity was measured using
Caspase-Glo 3/7 Assay kit (Promega). Annexin V/PI staining and
ﬂow cytometry was also used to measure apoptosis.
2.10. Cell fractionation
A375 cells were washed with PBS and resuspended in hypotonic
buffer (10 mM HEPES, pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM
DTT) containing 1 mM sodium orthovanadate, 1 mM phenylmeth-
ylsulfonyl ﬂuoride and 1% protease inhibitor cocktail (Sigma) and
incubated on ice for 15 min. Cells were then homogenized and
the percentage of nuclei was checked by trypan blue staining. Pel-
let was collected at 2000g for 10 min. The supernatant contains
the cytoplasm.Fig. 2. Endogenous eIF3f is phosphorylated by CDK11p46 during apoptosis. A375
cells were treated with 0.5 lg/ml anti-Fas with or without pretreatment with
caspase 3 inhibitor (DEVD-FMK) for 36 h. (A) Cells were lysed and immunobloted
with CDK11 and a-tubulin antibodies. (B) 2D-SDS–PAGE showed increased
phosphorylation of eIF3f during apoptosis. (C) Increased phosphorylation of
endogenous eIF3f in CDK11p46 transfected cells.3. Results
3.1. CDK11p46 phosphorylates eIF3f at more than one site during
apoptosis
We have shown that CDK11p46 phosphorylates eIF3f at Ser46
[8]. To investigate if it is the only phosphorylation site in eIF3f that
is phosphorylated by CDK11p46, Ser46 of eIF3f was mutated to ala-
nine. A recombinant GST-eIF3fS46A mutant protein was made and
incubated with CDK11p46 that immunoprecipitated from apoptotic
cells. The phosphorylation level of eIF3fS46A by CDK11p46 was lower
compared to wild-type eIF3f, but there was still a signiﬁcant level
of phosphorylation (Fig. 1A). To investigate other phosphorylation
sites, we used deletion constructs of eIF3f (Fig. 1C) as substrates in
kinase assays. CDK11p46 was immunoprecipitated from apoptotic
cell lysate and incubated with equal amount of the indicated sub-
strates (Fig. 1B, right panel). Phosphorylation was seen with eIF3f
deletions #1 and #4, but not with GST control, #2 and #3
(Fig. 1B, left panel). Ser46 is present in eIF3f-4 protein, but not in
eIF3f-1 protein (Fig. 1C), and eIF3f-2 is not phosphorylated. These
data suggested that additional phosphorylation sites might exist
between residues 106 and 170 in eIF3f.
To identify additional phosphorylation site(s) in eIF3f, the trun-
cated eIF3f-1 protein was incubatedwith CDK11p46 immunoprecip-
itated from apoptotic cells. After the kinase reaction, eIF3f-1 was
separated by SDS–PAGE, digested in-gel with trypsin and subjected
to MS analysis. The spectrum for the eIF3f-1 phosphopeptide (resi-
dues Y106–K126) is shown in Fig. 1D. Identiﬁcation of a phosphory-
lated Thr119 is seen by analysis of b ions and y ions. A gain ofphosphate after the y8 or b14 ion was observed. To verify the MS
result, we mutated Thr119 to alanine in eIF3f-1 to create eIF3f-1TA
and used it as the substrate in a kinase assay. It is clear that the
T119Amutationabolished thephosphorylationbyCDK11p46 (Fig. 1E).
We then investigated the endogenous threonine phosphoryla-
tion status of eIF3f in apoptotic cells. The threonine phosphoryla-
tion of eIF3f was seen and the maximum phosphorylation level
was seen at 36 h after treatment (Fig. 1F). These data are consistent
with our previous in vitro kinase assay data and endogenous serine
phosphorylation data that eIF3f is phosphorylated by CDK11p46
after apoptotic stimulation, especially around 36 h [8]. Hence, thre-
onine phosphorylation of eIF3f, likely by CDK11p46, also occurs
endogenously during apoptosis.
3.2. Endogenous phosphorylation of eIF3f by CDK11p46
To further conﬁrm the endogenous phosphorylation of eIF3f by
CDK11p46 during apoptosis, A375 cells were treated with anti-Fas
and/or caspase 3 inhibitor (DEVD-FMK). CDK11p46 was produced
in anti-Fas treated cells, whereas caspase 3 inhibitor blocked the
production of CDK11p46 (Fig. 2A). eIF3f was immunoprecipitated
fromthesecells followedby two-dimensionalSDS–PAGEand immu-
noblot with eIF3f antibody. Phosphorylated eIF3f was separated
from un-phosphorylated eIF3f by different pI. Under normal condi-
tion, 25% of endogenous eIF3f protein is phosphorylated (Fig. 2B).
During apoptosis, phosphorylated eIF3f is signiﬁcantly increased
to 52% of total eIF3f. The addition of caspase 3 inhibitor reversed this
phosphorylation (Fig. 2B). This observation is consistent with our
previousdata supporting that eIF3f is phosphorylated endogenously
during apoptosis and this is presumably done by CDK11p46.
To analyze whether endogenous eIF3f is directly phosphory-
lated by CDK11p46, A375 cells were transfected with CDK11p46.
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in CDK11p46 transfected cells compared to vector transfected cells
(Fig. 2C). The membrane was also blotted with eIF3f antibody to
show that the higher phosphorylation level is not due to higher
protein level of eIF3f. This result strongly suggests that eIF3f is
directly phosphorylated by CDK11p46 in living cells.
3.3. Phosphorylation of eIF3f by CDK11p46 regulates its function in
translation and apoptosis
We have shown that eIF3f inhibits translation and induces
apoptosis in tumor cells [11]. To examine whether phosphoryla-Fig. 3. Phosphorylation of eIF3f by CDK11p46 is important for the inhibition of translati
pcDNA3-eIF3f, or pcDNA3-eIF3fSATA and pGL3-SV40 carrying the luciferase reporter gene.
luminometer. (B) RT-PCR was performed as described. Untransfected A375 cells and reac
by Acridine Orange/Ethidium Bromide staining. (D, E) Luciferase mRNA was translate
recombinant proteins. Synthesized luciferase activity was measured with a luminomete
measured 48 h after transfection.tion of eIF3f by CDK11p46 regulates its function, we mutated the
Ser46 and Thr119 to alanine (A). This yielded eIF3fSATA. Translation
was compared between wild-type and mutated eIF3f transfected
cells using a luciferase reporter system. Luciferase synthesis inhibi-
tion was signiﬁcantly attenuated in eIF3fSATA-transfected cells
(Fig. 3A). This effect was not at the mRNA level as conﬁrmed by
RT-PCR, but at the translation level (Fig. 3B). Alanine mutation also
diminished the apoptosis induction by wild-type eIF3f (Fig. 3C).
These results indicated that the eIF3f phosphorylation regulates
its function in translation and apoptosis.
To further examine if CDK11p46 is responsible for these effects,
we used a kinase dead mutant form of CDK11p46–CDK11p46M [8].on and induction of apoptosis. (A) A375 cells were co-transfected with pcDNA3, or
At 24 h post-transfection, cells were lysed and luciferase activity was measured by a
tions without reverse transcription served as controls. (C) Apoptosis was measured
d in an in vitro translation system in the presence of buffer, GST, or indicated
r. (F) A375 cells were transfected with indicated plasmids. Caspase 3/7 activity was
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the in vitro translation assay, wild-type CDK11p46 signiﬁcantly
inhibited translation while CDK11p46M attenuated the inhibition
(Fig. 3D). As shown previously by our group, eIF3f can inhibit trans-
lation (Fig. 3E) [11]. When eIF3f and CDK11p46 were added to-
gether, they inhibited translation synergetically (Fig. 3E).
However, CDK11p46M abolished this synergetic effect (Fig. 3E).
CDK11p46M also attenuated the apoptosis induction by CDK11p46
(Fig. 3F). These results further supported that CDK11p46 is the
kinase that regulates eIF3f function.
3.4. Phosphorylation by CDK11p46 increases the association of eIF3f
with the eIF3 core complex during apoptosis
We next investigated the effect of eIF3f phosphorylation by
CDK11p46 on its association with the eIF3 core complex during
apoptosis. We found that there were equivalent amounts of total
eIF3f in cells whether or not they underwent apoptosis (Fig. 4A,
second panel). However, we saw a signiﬁcant increase of endoge-
nous eIF3f that associates with eIF3 complex by co-immunopre-Fig. 4. Phosphorylation of eIF3f by CDK11p46 increases the association of eIF3f with other
Fas for indicated time. (A) Cell lysates were immunoprecipitated with eIF3 or eIF3f antibo
carried out with CDK11p46 transfected cells. (B) Cell lysates were immunoprecipitated w
were fractionated and immunoprecipitated with eIF3b antibody followed by immu
immunoblotted with eIF3f, CDK11 and a-tubulin antibodies without immunoprecipitatio
Annexin V/PI staining and ﬂow cytometry analysis.cipitation after apoptotic stimulation, especially at 36 h (Fig. 4A,
ﬁrst panel). This increase is speciﬁc because another eIF3 subunit
eIF3b remains the same during apoptosis (Fig. 4A, third panel). To
verify our ﬁndings, we performed co-immunoprecipitation with
speciﬁc antibodies against the eIF3b and eIF3f. Consistent with
our previous observation, we observed an increased interaction
of eIF3f with eIF3b at 36 h after apoptotic stimulation (Fig. 4B, ﬁrst
panel). The association of eIF3f with eIF3b diminished after 48 h.
There was no signiﬁcant change in eIF3b protein level during
apoptosis. These results indicated that endogenous eIF3f speciﬁ-
cally increases its association with other eIF3 subunits during
apoptosis.
To further conﬁrm that the increased association of eIF3f with
the eIF3 core complex during apoptosis is related to the phosphor-
ylation of eIF3f by CDK11p46, we performed a similar experiment
using CDK11p46 transfected cells. We noted an increased associa-
tion of eIF3f to the eIF3 complex only in CDK11p46 transfected cells,
but not in vector control cells (Fig. 4A). This result further veriﬁed
that CDK11p46 is responsible for the increased association of eIF3f
with the eIF3 core complex.eIF3 subunits during apoptosis. A375 cells were treated with staurosporine or anti-
dy followed by immunoblot with eIF3f or eIF3b antibody. The same experiment was
ith eIF3b antibody followed by immunoblot with eIF3f or eIF3b antibody. (C) Cells
noblot with eIF3f, eIF3b, eIF3c and eIF3a antibodies. Cell fractions were also
n. S: soluble fraction; P: pellet fraction. (D) Cells were analyzed for apoptosis using
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eIF3f association with the eIF3 core complex during apoptosis, we
performed cell fractionation in A375 cells. Most nuclei were in the
pellet (P) fraction as was observed by a microscope and the loca-
tion of CDK11p110 which is mainly a nuclear protein (Fig. 4C). Cyto-
plasm was mainly in the soluble (S) fraction, as proved by the
location of a-tubulin which is a cytoplasmic protein (Fig. 4C). We
found that endogenous eIF3f associates with eIF3b contiguously
in the S fraction during apoptosis (Fig. 4C). However, eIF3f only
associated with eIF3b in the P fraction at 36 h after apoptotic stim-
ulation. There was no change in the interaction between eIF3b and
eIF3a or eIF3c during apoptosis (Fig. 4C). eIF3f and two of the core
subunits, eIF3b and eIF3c, were localized in both S and P fractions
during apoptosis, but more in the S fraction. eIF3a is predomi-
nantly localized in the S fraction.
We conﬁrmed apoptosis induction by Annexin V staining and
ﬂow cytometry analysis. There was a gradual increase in apoptosis
over time, up to 46% of apoptosis at 48 h (Fig. 4D). CDK11p46 was
produced 24 h after apoptotic stimulation. It peaked at 36 h and
then started to decrease after 48 h (Fig. 4C, last row). Furthermore,
CDK11p46 was predominantly located in the P fraction where eIF3f
increased its association with eIF3b. Therefore, the events of
CDK11p46 production, eIF3f phosphorylation, and the association
of eIF3f with eIF3b occur coincidentally with each other.Fig. 5. The effect of the eIF3f phosphorylation sites mutation on its association with
eIF3b and apoptosis. (A) A375 cells were transfected with pcDNA3, eIF3f, eIF3fSATA
(phosphorylation sites inactivated) or eIF3fSETE (phosphorylation mimic) plasmids.
Cell lysates were immunoprecipitated with eIF3b antibody followed by immuno-
blot with eIF3f antibody. Cell lysates were also used for Western blot using eIF3f
and a-tubulin antibodies. (B, C) A375 cells were transfected with indicated
plasmids. Caspase 3/7 activity was measured 48 h after transfection.To investigate whether the speciﬁc eIF3f phosphorylation by
CDK11p46 alters the association between eIF3f and eIF3 core com-
plex, we performed co-immunoprecipitation with speciﬁc antibod-
ies against the eIF3b and eIF3f in eIF3f, eIF3fSATA or eIF3fSETE
(phosphorylation mimic mutant) transfected cells. As predicted,
there is a 40% increased association between eIF3fSETE and eIF3b
(Fig. 5A). The association between eIF3fSATA and eIF3b is only
slightly less than eIF3f presumably due to the low level of endog-
enous phosphorylation of eIF3f in un-stimulated cells. To examine
whether eIF3fSATA mutant attenuates apoptosis in CDK11p46 over-
expressing cells, we co-transfected CDK11p46 with wild-type or
mutant eIF3f followed by apoptosis assay. As predicted, eIF3fSATA
mutant did attenuate apoptosis in CDK11p46 overexpressing cells
compared to wild-type eIF3f (Fig. 5B). To investigate whether the
phosphor-mimic eIF3fSETE mutant promotes apoptosis, we trans-
fected eIF3fSETE alone or with CDK11p46 or CDK11p46M into A375
cells. eIF3fSETE mutant alone did induce more apoptosis than
wild-type eIF3f (Fig. 5C). Co-transfection with both eIF3fSETE and
CDK11p46 induced even more apoptosis than eIF3fSETE alone, pre-
sumably due to the phosphorylation of the endogenous eIF3f
(Fig. 5C). Furthermore, CDK11p46 M mutant attenuated this syner-
getic effect (Fig. 5C). These results further indicated that the phos-
phorylation of eIF3f by CDK11p46 contributes to its increased
association with eIF3 core complex and apoptosis.4. Discussion
We identiﬁed another phosphorylation site (Thr119) in eIF3f
that is phosphorylated by CDK11p46 during apoptosis. Thr119 is lo-
cated in the Mov34 domain of eIF3f which is important for both the
translational inhibitory function of eIF3f [11] and the protein–pro-
tein interaction of eIF3f with CDK11p46 [8]. It was also suggested by
another group that the Mov34 domain plays an important role in
complex assembly [15]. There is the possibility that phosphoryla-
tion of this site regulates the function of Mov34 domain. Further
studies are necessary to clarify this issue. We have also presented
data to show the direct phosphorylation of eIF3f by CDK11p46
endogenously which conﬁrmed our previous observations. Results
from the present study suggest that phosphorylation of eIF3f by
CDK11 may contribute to the regulation of protein synthesis and
apoptosis.
Our present study suggested that the association of eIF3f with
the eIF3 complex appears to be strengthened in the insoluble frac-
tion of cells during apoptosis. This observation suggested that dur-
ing apoptosis, eIF3f was incorporated into a larger complex or
organelle that also contains eIF3b and eIF3c, but not eIF3a. This lar-
ger complex and organelle can be precipitated with the nucleus in
the insoluble fraction of the cell. eIF3f is also associated with a
smaller complex in the soluble fraction of the cell consisting of
eIF3a, b and c in both control and apoptotic cells. It was suggested
that eIF3 is a dynamic complex. Our data also support this hypoth-
esis. eIF3 complexes in the cell may contain different subunits and
variable numbers of different subunits. According to our present
data, there are at least two different types of eIF3 complexes that
exist in the cell. One eIF3 complex lacks eIF3a and eIF3f, while
the other eIF3 complex consists of eIF3a–c and eIF3f. These differ-
ent eIF3 complexes are localized in different subcellular fractions.
Based on our observations, the model that we propose depicts that
the phosphorylation of eIF3f by CDK11p46 enhances its binding to
different sub-fractions of the eIF3 complex during apoptosis. This
may regulate translation initiation.
A signiﬁcant inhibition of overall protein synthesis has been ob-
served in various cell types when cells are committed to apoptosis
[16–18]. Presently it is not completely clear how the eIF3f phos-
phorylation regulates protein synthesis and apoptosis. However,
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degradation of 28S rRNA and decreases the 60S ribosomal subunit
[11]. There is a physiologic link between rRNA degradation and the
inhibition of protein synthesis during apoptosis. 28S rRNA is selec-
tively degraded in Jurkat T cells and U937 cells by death receptor
engagement [19]. It was suggested that the ribosome is a speciﬁc
target for death effectors during apoptosis and that a caspase/
Bcl2 independent pathway exists to activate its destruction. There-
fore, phosphorylation of eIF3f may regulate its role in ribosome
degradation, which may contribute to apoptosis. Our data also sug-
gested that the phosphorylated eIF3f may predominantly localize
to the nucleus. Other eIF3 subunits, such as eIF3a, eIF3e and eIF3b,
have been reported to have nuclear localization and Dunand-Sau-
thier et al. suggested that eIF3 is a dynamic complex [20–22].
Our data also suggest that eIF3 complex may exist in both cyto-
plasm and nucleus. The cytoplasmic eIF3 complex contains all of
the eIF3 subunits, whereas the nuclear eIF3 complex contains only
some eIF3 subunits. According to our present data, the nuclear eIF3
complex at least contains eIF3b and eIF3c, with phosphorylated
eIF3f joining the complex during apoptosis. However, the nuclear
eIF3 complex is highly possible to have functions other than trans-
lation initiation. It is known that the synthesis of ribosomes in
eukaryotes takes place in nucleus [23] and then ribosomes were
exported to the cytoplasm. There was evidence that eIF3j has a
dual function in processing 20S pre-rRNA and translation initiation
[24]. Cyclin-dependent kinases (CDKs) have been suggested to be
involved in ribosome biogenesis and nucleolar organization [25].
Therefore, CDK11p46 may regulate the function of the nuclear
eIF3 complex by phosphorylating eIF3f. Further studies of how
eIF3f phosphorylation regulates its function will reﬁne insights
into the mechanism and regulation of translation initiation, apop-
totic signaling, and tumorigenesis.
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